-
Mechanisms of response and resistance to Olaparib and Durvalumab in treatment of glioblastomas and IDH-mutated astrocytomas
https://braincanada.ca/fr/subventions-financées/mechanisms-of-response-and-resistance-to-olaparib-and-durvalumab-in-treatment-of-glioblastomas-and-idh-mutated-astrocytomasGlioblastoma multiforme and high grade astrocytomas are aggressive brain tumors that are difficult to treat. Project Overview Glioblastoma multiforme and high grade astrocytomas are aggressive brain tumors that are difficult to treat. These tumors have genetic changes that affect their ability to...
-
Mechanisms of Synaptic Dysfunction in Amyotrophic Lateral Sclerosis
https://braincanada.ca/fr/subventions-financées/mechanisms-of-synaptic-dysfunction-in-amyotrophic-lateral-sclerosisThis project will focus on unique roles of FUS (an ALS gene/protein) at the junction where neurons connect, called the synapse. Project Overview This project will focus on unique roles of FUS (an ALS gene/protein) at the junction where neurons connect, called the synapse. Most of the work done on...
-
Mechanisms underlying treatment-induced language recovery post-stroke
https://braincanada.ca/fr/subventions-financées/mechanisms-underlying-treatment-induced-language-recovery-post-strokeIn Canada, one individual suffers a stroke every seven minutes. Project Overview In Canada, one individual suffers a stroke every seven minutes. Of those who survive, roughly 30% will have aphasia, a difficulty speaking with- or understanding others. Aphasia can have a significant negative impact...
-
Mechanistic Studies of Metabolite-Signaling Defects Causing Seizures
https://braincanada.ca/fr/subventions-financées/mechanistic-studies-of-metabolite-signaling-defects-causing-seizuresOur research program is centered on investigating the important contributions of metabolism to brain health. Project Overview Our research program is centered on investigating the important contributions of metabolism to brain health. It is generally well-accepted that proper nutrition is a major...
-
Methylphenidate primed iTBS for apathy in neurocognitive disorders
https://braincanada.ca/fr/subventions-financées/methylphenidate-primed-itbs-for-apathy-in-neurocognitive-disordersApathy (reduced goal-directed behaviour) is common in persons with dementia and is associated with lower quality of life, increased dependence and faster decline. Project Overview Apathy (reduced goal-directed behaviour) is common in persons with dementia and is associated with lower quality of...
-
Microbiota-Microglia Interactions in Pediatric Inflammatory Bowel Disease
https://braincanada.ca/fr/subventions-financées/microbiota-microglia-interactions-in-pediatric-inflammatory-bowel-diseaseDespite the recent advances in our understanding between the connection between the microbes living in the gut and our mental health, there remains a wide knowledge gap in understanding how the brain is negatively impacted in disorders with inflammation of the gut. Project Overview Despite the...
-
Microfluidic Screening Technology for the Discovery of Function-Modifying Antibodies Against Membrane Protein Targets
https://braincanada.ca/fr/subventions-financées/microfluidic-screening-technology-for-the-discovery-of-function-modifying-antibodies-against-membrane-protein-targetsAntibody (Ab)-based therapeutics are the fastest growing class of drugs, with approximately 60 approved molecules that represent a market of over $80B. Project Overview Antibody (Ab)-based therapeutics are the fastest growing class of drugs, with approximately 60 approved molecules that represent a...
-
Microglia and Vapourized Cannabis
https://braincanada.ca/fr/subventions-financées/microglia-and-vapourized-cannabisMicroglia, the brain’s resident immune cells, are vital for healthy brain function. Project Overview Microglia, the brain’s resident immune cells, are vital for healthy brain function. This is partially accomplished through their interactions with the primary brain cells, neurons, and those cells’...
-
MicroRNA biomarkers: Using Tears to Assess Alzheimer’s Disease
https://braincanada.ca/fr/subventions-financées/microrna-biomarkers-using-tears-to-assess-alzheimer-s-diseaseAlzheimer’s disease (AD) is the most common form of dementia and 7th leading cause of death in North-America. Project Overview Alzheimer’s disease (AD) is the most common form of dementia and 7th leading cause of death in North-America. It affects memory, thinking and behavior, thus causing major...
-
Mind Over Matter
https://braincanada.ca/fr/subventions-financées/mind-over-matterPartners and Donors Women's Brain Health Initiative